Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0V4WT
|
||||
Former ID |
DIB020644
|
||||
Drug Name |
paxilline
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [539460] | ||
Structure |
Download2D MOL |
||||
Formula |
C27H33NO4
|
||||
InChI |
InChI=1S/C27H33NO4/c1-24(2,30)23-20(29)14-18-21(32-23)10-11-25(3)26(4)15(9-12-27(18,25)31)13-17-16-7-5-6-8-19(16)28-22(17)26/h5-8,14-15,21,23,28,30-31H,9-13H2,1-4H3
|
||||
InChIKey |
ACNHBCIZLNNLRS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Maxi K potassium channel | Target Info | Blocker (channel blocker) | [534285] | |
Oxysterols receptor LXR-alpha | Target Info | Agonist | [526684] | ||
Pathway Interaction Database | RXR and RAR heterodimerization with other nuclear receptor | ||||
Reactome | cGMP effects | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.